Related Experiment Videos
Mycoplasma pneumoniae and its role as a human pathogen
Ken B Waites1, Deborah F Talkington
1Department of Pathology, WP 230, University of Alabama at Birmingham, 619 19th St. South, Birmingham, AL 35249, USA. waites@path.uab.edu.
Clinical Microbiology Reviews
|October 19, 2004
Summary
Mycoplasma pneumoniae infections can cause serious illness in children and adults, sometimes affecting multiple organs. Understanding the immune response is key to improving diagnosis and prevention of this significant bacterial pathogen.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Immunology
Background:
- Mycoplasma pneumoniae is an under-recognized cause of significant morbidity in children and adults.
- Infections can lead to severe, multi-organ system involvement, occasionally requiring hospitalization.
- Disease severity is linked to the host's immune response.
Purpose of the Study:
- To highlight the clinical significance of Mycoplasma pneumoniae infections.
- To discuss the pathogenesis and extrapulmonary manifestations.
- To review current management and future diagnostic/preventive strategies.
Main Methods:
- Literature review of Mycoplasma pneumoniae infections.
- Analysis of clinical presentations and extrapulmonary complications.
- Summary of treatment options and emerging research.
Main Results:
- Mycoplasma pneumoniae infections can result in severe extrapulmonary complications affecting major organ systems.
- Autoimmune responses and direct bacterial invasion contribute to disease severity.
- Accumulating evidence suggests a role in chronic lung conditions like asthma.
Conclusions:
- Mycoplasma pneumoniae infections warrant greater clinical attention due to their potential severity and extrapulmonary effects.
- Further research into pathogenesis and host immune responses is crucial for improved diagnostics and prevention.
- Current treatment options include macrolides, tetracyclines, and fluoroquinolones.